Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 3 PART I, 1996, Pages 661-667

  Mandelbrot, Laurent ^a   Mayaux, Marie Jeanne ^d   Bongain, André ^e   Berrebi, Alain ^f   Moudoub Jeanpetit, Yasmine ^d   Bénifla, Jean Louis ^b   Ciraru Vigneron, Nicole ^c   Le Chenadec, Jérôme ^d   Blanche, Stéphane ^d   Delfraissy, Jean François ^d  

^a Université Paris Descartes   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d BICÊTRE HOSPITAL   (France)

^e University Hospital of Nice University of Nice Sophia Antipolis   (France)

^f Serv Univ Psychiat l'Enfant l'A   (France)

Author keywords

Acquired immunodeficiency syndrome; Human immunodeficiency virus; Mother to child transmission; Obstetric factors

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY PRODUCTION; ARTICLE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MOTHER CHILD RELATION; PREGANGLIONIC NERVE; PRIORITY JOURNAL; RISK ASSESSMENT; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FRANCE; HIV-1; HUMANS; INFANT, NEWBORN; LABOR, INDUCED; LABOR, OBSTETRIC; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 0013480098     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1053/ob.1996.v175.a75478     Document Type: Article

References (25)

1. Brossard Y, Aubin JT, Mandelbrot L, et al. Frequency of early in utero HIV1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS 1995;9:359-66.
2. Burgard M, Mayaux MJ, Blanche S, et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. N Engl J Med 1992;327:1192-7.
3. Bryson W, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-l. N Engl J Med 1992;327:1246-7.
4. De Rossi A, Ometto L, Mammano F, et al. Vertical transmission of HIV-l: lack of detectable virus in peripheral blood cells of infected children at birth. AIDS 1992;6:1117-20.
5. Krivine A, Firtion G, Cao L, Francoual C, Henrion R, Lebon P. HIV replication during the first weeks of life. Lancet 1992;339:1187-9.
6. Rouzioux C, Costagliola D, Burgard M, et al. Estimated timing of mother-to-child human immunodeficiency virus type I transmission by use of a Markov model. Am J Epidemiol 1995;142:1330-7.
7. Amirhessami-Aghila N, Spector SA. Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection. J Virol 1991;65:2231-6.
8. Pons JC, Brossard Y, Jrad I, et al. Transplacental microtransfusions of maternal blood toward the fetus: is there a relation with HIV vertical transmission? In: Proceedings of the second international symposium on AIDS and reproduction. Montpellier: Sauramps Medical, 1994.
9. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994;343:1464-7.
10. Mayaux MJ, Blanche S, Rouzioux G, et al. Maternal factors associated with perinatal HIV-1 transmission: The French cohort study-7 years of follow-up observation. J Acquir Immune Dene Syndr Hum Retrovirol 1995;8:188-94.
11. Blanche S, Rouzioux C, Guilhard Moscato ML, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989;320:1643-8.
12. Cadwell MB, Oxtoby MJ, Simonds RJ, Lindegren ML, Rogers MF. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Moral Wkly Rep 1994;43:1-10.
13. Ryder RW, Nsa W, Hassing SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaïre. N Engl J Med 1988;320:1637-42.
14. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
15. St. Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal, immunologic, virologic and placental factors. JAMA 1993;269:2853-9.
16. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
17. Viscarello RR, DeGennaro NJ, Griffith SM, Andiman W, Hobbins JC. Does an antepartum invasive procedure increase the risk of perinatal transmission of HIV-1? [Abstract]. Am J Obstet Gynecol 1992;166:384.
18. William-Herman D, Wara D, Levy J, Benson M, Dattel B, Landers D. Risk factors for perinatal HTV1 transmission. In: Proceedings of the Ninth International Conference on AIDS, 1993; Berlin. PO-B05-1064.
19. Minkoff H, Burns DN, Landesman S, et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995;173:585-9.
20. Duliége AM, Amos CI, Felton S, Biggar RJ, International Registry of HIV-exposed Twins, Goedert JJ. Birth order, delivery route and concordance in the transmission of human immunodeficiency virus type I from mothers to twins. J Pediatr 1995;126:625-32.
21. Nair P, Alger L, Hines S, et al. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:298-302.
22. Temmerman M, N'Yong'o AO, Bwayo J, et al. Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection. Am J Obstet Gynecol 1995;172:700-5.
23. European Collaborative Study. Risk factors for mother-tochild transmission of HIV-1. Lancet 1992;339:1007-12.
24. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988;31:553-61.
25. Siena Consensus Workshop II. Strategies for prevention of perinatal transmission of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:161-75.